Banco Santander, S.A. I Mab Transaction History

Banco Santander, S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$8.27 - $18.43 $2.48 Million - $5.53 Million	-300,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$12.54 - $46.93 $3.76 Million - $14.1 Million	300,000 New	300,000 $4.87 Million
Q4 2021 Feb 09, 2022	SELL	$45.28 - $74.5 $14 Million - $23.1 Million	-310,000 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$57.18 - $84.43 $17.7 Million - $26.2 Million	310,000 New	310,000 $22.5 Million

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $77.3M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Santander, S.A. with notifications on news.